Explore the PRC

Content Type
Articles
Clinical & Surgical Tools
Meetings & Events
Online Learning Ideas & Innovation
Podcasts
Position Statements & Guidelines
Videos
Webinars
Categories
Canadian Journal of Ophthalmology
COS Annual Meeting Resources
Covid-19 Resources
Equity, Diversity and Inclusion
Financial Resources
For Accreditation
For Medical Students
For Ophthalmologists
For Residents & Fellows
MOC Section 1 activities
MOC Section 3 activities
Neuro-Ophthalmology
Physician Wellness
Practice Management
Sally Letson Symposium
Subspecialities
- Cataract Surgery
- Cornea, External Disease and Refractive Surgery
- Glaucoma
- Neuro-ophthalmology
- Ocular Regenerative Medicine
- Oculoplastics
- Oncology
- Ophthalmic Pathology
- Pediatric Ophthalmology and Strabismus
- Public Health and Global Ophthalmology
- Retina
- Uveitis
- Vision Rehabilitation
Women in Ophthlamology

Corneal Neuropathic Pain General Information for Patients and Providers

Canadian Ophthalmological Society (COS) Joint Position Statement on Biosimilar Drugs

Non-hospital Surgical Centres Advocacy Principles

Position Statement by the Canadian Ophthalmological Society (COS) Regarding Vision therapy (VT), or Behavioural Optometry

Canadian Ophthalmological Society (COS) Joint position paper calling for a complete ban on scleral tattooing and eyeball jewellery implantation in Manitoba

Evidence-based clinical practice guidelines for the periodic eye examination in children aged 0-5 years in Canada

Canadian Glaucoma Society Evidence-Based Recommendations for the Risk of Acute Angle Closure Glaucoma with Routine Use of Hyoscine-n-Butylbromide (Buscopan) for Gastroenterological Procedures

Advisory Statement: Regarding Light Therapy (Photobiomodulation) for Macular Degeneration

Position statement by the Canadian Ophthalmological Society (COS) Regarding Diversity and Inclusion

Load More

Loading resources...